terbutaline has been researched along with Long QT Syndrome in 1 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clifton, GD | 1 |
| Hunt, BA | 1 |
| Patel, RC | 1 |
| Burki, NK | 1 |
1 trial available for terbutaline and Long QT Syndrome
| Article | Year |
|---|---|
Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses.
Topics: Adult; Asthma; Blood Glucose; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Ele | 1990 |